{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:39:02Z","timestamp":1773013142823,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03CA242562-01A1"],"award-info":[{"award-number":["R03CA242562-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Multi-gene panel testing allows many cancer susceptibility genes to be tested quickly at a lower cost making such testing accessible to a broader population. Thus, more patients carrying pathogenic germline mutations in various cancer-susceptibility genes are being identified. This creates a great opportunity, as well as an urgent need, to counsel these patients about appropriate risk-reducing management strategies. Counseling hinges on accurate estimates of age-specific risks of developing various cancers associated with mutations in a specific gene, ie, penetrance estimation. We propose a meta-analysis approach based on a Bayesian hierarchical random-effects model to obtain penetrance estimates by integrating studies reporting different types of risk measures (eg, penetrance, relative risk, odds ratio) while accounting for the associated uncertainties. After estimating posterior distributions of the parameters via a Markov chain Monte Carlo algorithm, we estimate penetrance and credible intervals. We investigate the proposed method and compare with an existing approach via simulations based on studies reporting risks for two moderate-risk breast cancer susceptibility genes, ATM and PALB2. Our proposed method is far superior in terms of coverage probability of credible intervals and mean square error of estimates. Finally, we apply our method to estimate the penetrance of breast cancer among carriers of pathogenic mutations in the ATM gene.<\/jats:p>","DOI":"10.1093\/biomtc\/ujae038","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T20:24:26Z","timestamp":1717187066000},"source":"Crossref","is-referenced-by-count":4,"title":["Bayesian meta-analysis of penetrance for cancer risk"],"prefix":"10.1093","volume":"80","author":[{"given":"Thanthirige Lakshika M","family":"Ruberu","sequence":"first","affiliation":[{"name":"Department of Mathematical Sciences, University of Texas at Dallas , Richardson, TX 75080 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5177-8598","authenticated-orcid":false,"given":"Danielle","family":"Braun","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Harvard T.H. Chan School of Public Health , Boston, MA 02115 , United States"},{"name":"Department of Data Science, Dana Farber Cancer Institute , Boston, MA 02215 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8783-5961","authenticated-orcid":false,"given":"Giovanni","family":"Parmigiani","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Harvard T.H. Chan School of Public Health , Boston, MA 02115 , United States"},{"name":"Department of Data Science, Dana Farber Cancer Institute , Boston, MA 02215 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7758-4460","authenticated-orcid":false,"given":"Swati","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Mathematical Sciences, University of Texas at Dallas , Richardson, TX 75080 , United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"2024070908161078000_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12609-018-0269-8","article-title":"Managing patient with mutations in PALB2, CHEK2, or ATM","volume":"10","author":"Acevedo","year":"2018","journal-title":"Current Breast Cancer Reports"},{"key":"2024070908161078000_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cancergen.2015.06.001","article-title":"Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies","volume":"208","author":"Aloraifi","year":"2015","journal-title":"Cancer Genetics"},{"key":"2024070908161078000_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0022029905001147","article-title":"Ataxia\u2013telangiectasia genes and breast cancer risk in a French family study","volume":"72","author":"Andrieu","year":"2005","journal-title":"Journal of Dairy Research"},{"key":"2024070908161078000_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"2024070908161078000_bib5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10897-018-0238-4","article-title":"A clinical decision support tool to predict cancer risk for commonly tested cancer-related germline mutations","volume":"27","author":"Braun","year":"2018","journal-title":"Journal of Genetic Counselling"},{"key":"2024070908161078000_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1399-0004.2008.00987.x","article-title":"ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1\/BRCA2 mutations","volume":"73","author":"Brunet","year":"2008","journal-title":"Clinical Genetics"},{"key":"2024070908161078000_bib7","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-10-3958","article-title":"Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer","volume":"71","author":"Casadei","year":"2011","journal-title":"Cancer Research"},{"key":"2024070908161078000_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN guidelines insights: genetic\/familial high-risk assessment: breast and ovarian, version 2.2017","volume":"15","author":"Daly","year":"2017","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"2024070908161078000_bib9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00402-015-2258-y","article-title":"Adverse effects associated with the direct anterior approach for total hip arthroplasty: a Bayesian meta-analysis","volume":"135","author":"De\u00a0Geest","year":"2015","journal-title":"Archives of Orthopaedic and Trauma Surgery"},{"key":"2024070908161078000_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.19.00043","article-title":"Validation of a semiautomated natural language processing\u2013based procedure for meta-analysis of cancer susceptibility gene penetrance","volume":"3","author":"Deng","year":"2019","journal-title":"JCO Clinical Cancer Informatics"},{"key":"2024070908161078000_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clincal Trials"},{"key":"2024070908161078000_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/9781118951651","volume-title":"Network Meta-Analysis for Decision-Making\u00a0(Statistics in Practice)","author":"Dias","year":"2018"},{"key":"2024070908161078000_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes-association analysis in more than 113,000 women","volume":"384","author":"Dorling","year":"2021","journal-title":"The New England Journal of Medicine"},{"key":"2024070908161078000_bib14","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1158\/1078-0432.CCR-08-0210","article-title":"Penetrance analysis of the PALB2 c.1592delT founder mutation","volume":"14","author":"Erkko","year":"2008","journal-title":"Clinical Cancer Research"},{"key":"2024070908161078000_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ng0397-307","article-title":"Heterozygous ATM mutations do not contribute to early onset of breast cancer","volume":"15","author":"Fitzgerald","year":"1997","journal-title":"Nature Genetics"},{"key":"2024070908161078000_bib16","doi-asserted-by":"crossref","first-page":"e2189","DOI":"10.1002\/rcs.2189","article-title":"New technology-based assistive techniques in total knee arthroplasty: a Bayesian network meta-analysis and systematic review","volume":"17","author":"Gao","year":"2021","journal-title":"The International Journal of Medical Robotics and Computer Assisted Surgery"},{"key":"2024070908161078000_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr2919","article-title":"Rare variants in the ATM gene and risk of breast cancer","volume":"13","author":"Goldgar","year":"2011","journal-title":"Breast Cancer Research"},{"key":"2024070908161078000_bib18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"2024070908161078000_bib19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/jcpe.13238","article-title":"Regenerative surgical treatment of furcation defects: a systematic review and Bayesian network meta-analysis of randomized clinical trials","volume":"47","author":"Jepsen","year":"2020","journal-title":"Journal of Clinical Periodontology"},{"key":"2024070908161078000_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3747\/co.25.3707","article-title":"Ataxia\u2013telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review","volume":"25","author":"Jerzak","year":"2018","journal-title":"Current Oncology"},{"key":"2024070908161078000_bib21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/302808","article-title":"Bias and efficiency in family-based gene-characterization studies: conditional, prospective, retrospective, and joint likelihoods","volume":"66","author":"Kraft","year":"2000","journal-title":"The American Journal of Human Genetics"},{"key":"2024070908161078000_bib22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/109065700750065171","article-title":"The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer","volume":"4","author":"Kreiss","year":"2000","journal-title":"Genetic Testing"},{"key":"2024070908161078000_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00066","article-title":"Breast and ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women","volume":"1","author":"Kurian","year":"2017","journal-title":"JCO Precision Oncology"},{"key":"2024070908161078000_bib24","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"Clinvar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Research"},{"key":"2024070908161078000_bib25","doi-asserted-by":"crossref","first-page":"e68699","DOI":"10.7554\/eLife.68699","article-title":"Multi-syndrome, multi-gene risk modeling for individuals with a family history of cancer with the novel R package PanelPRO","volume":"10","author":"Lee","year":"2021","journal-title":"eLife"},{"key":"2024070908161078000_bib26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jmedgenet-2015-103452","article-title":"Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families","volume":"53","author":"Li","year":"2016","journal-title":"Journal of Medical Genetics"},{"key":"2024070908161078000_bib27","doi-asserted-by":"crossref","first-page":"e1007139","DOI":"10.1371\/journal.pgen.1007139","article-title":"An efficient Bayesian meta-analysis approach for studying cross-phenotype genetic associations","volume":"14","author":"Majumdar","year":"2018","journal-title":"PLoS Genetics"},{"key":"2024070908161078000_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-015-0787-z","article-title":"ATM gene mutations in sporadic breast cancer patients from Brazil","volume":"4","author":"Mangone","year":"2015","journal-title":"Springerplus"},{"key":"2024070908161078000_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/gepi.21971","article-title":"Penetrance of ATM gene mutations in breast cancer: a meta-analysis of different measures of risk","volume":"40","author":"Marabelli","year":"2016","journal-title":"Genetic Epidemiology"},{"key":"2024070908161078000_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06581-8","article-title":"Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls","volume":"9","author":"Momozawa","year":"2018","journal-title":"Nature Communications"},{"key":"2024070908161078000_bib31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.bjc.6602658","article-title":"Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia","volume":"93","author":"Olsen","year":"2005","journal-title":"British Journal of Cancer"},{"key":"2024070908161078000_bib32","volume-title":"Modeling in Medical Decision Making: A Bayesian Approach (Statistics in Practice)","author":"Parmigiani","year":"2002"},{"key":"2024070908161078000_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-28410-9","article-title":"Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects","volume":"13","author":"Plana","year":"2022","journal-title":"Nature Communications"},{"key":"2024070908161078000_bib34","first-page":"787","article-title":"What\u2019s new in genetic testing for cancer susceptibility?","volume":"30","author":"Plichta","year":"2016","journal-title":"Oncology (Williston Park, NY)"},{"key":"2024070908161078000_bib35","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/carcin\/bgl237","article-title":"Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer","volume":"28","author":"Pylk\u00e4s","year":"2007","journal-title":"Carcinogenesis"},{"key":"2024070908161078000_bib36","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2020"},{"key":"2024070908161078000_bib37","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/s41431-019-0467-5","article-title":"Exploring the effect of ascertainment bias on genetic studies that use clinical pedigrees","volume":"27","author":"Ranola","year":"2019","journal-title":"European Journal of Human Genetics"},{"key":"2024070908161078000_bib38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia\u2013telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Renwick","year":"2006","journal-title":"Nature Genetics"},{"key":"2024070908161078000_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12609-018-0289-4","article-title":"Moderate-penetrance predisposition to breast cancer","volume":"10","author":"Robson","year":"2018","journal-title":"Current Breast Cancer Reports"},{"key":"2024070908161078000_bib45_659_165224","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.22561","article-title":"Meta-analysis of breast cancer risk for individuals with PALB2 pathogenic variants","volume-title":"Genet Epidemiol","author":"Ruberu","year":"2024"},{"key":"2024070908161078000_bib40","article-title":"Cancer stat facts: female breast cancer","author":"Surveillance, Epidemiology, and End Results","year":"2018"},{"key":"2024070908161078000_bib41","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1158\/1055-9965.EPI-08-0414","article-title":"Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene","volume":"17","author":"Swift","year":"2008","journal-title":"Cancer Epidemiology and Prevention Biomarkers"},{"key":"2024070908161078000_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in heterozygous ATM mutation carriers","volume":"97","author":"Thompson","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"key":"2024070908161078000_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.genom.9.081307.164339","article-title":"Genetic predisposition to breast cancer: past, present, and future","volume":"9","author":"Turnbull","year":"2008","journal-title":"Annual Review of Genomics and Human Genetics"},{"key":"2024070908161078000_bib44","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1200\/JCO.2018.78.3977","article-title":"Inherited breast cancer in Nigerian women","volume":"36","author":"Zheng","year":"2018","journal-title":"Journal of Clinical Oncology"}],"container-title":["Biometrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/80\/2\/ujae038\/58478477\/ujae038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biometrics\/article-pdf\/80\/2\/ujae038\/58478477\/ujae038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T08:16:55Z","timestamp":1720513015000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biometrics\/article\/doi\/10.1093\/biomtc\/ujae038\/7685805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/biomtc\/ujae038","relation":{},"ISSN":["0006-341X","1541-0420"],"issn-type":[{"value":"0006-341X","type":"print"},{"value":"1541-0420","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,3,27]]},"article-number":"ujae038"}}